Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06526494Phase 2Withdrawn

Metformin and Vascular Function in Prediabetes

Role: lead

NCT03597568Not ApplicableCompleted

Resveratrol and Vascular Function in CKD

Role: lead

NCT03223883Phase 2Completed

Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease

Role: lead

All 3 trials loaded